<< Back to Corporate Member News

Effective for dates of service on or after January 1, 2012, the new J-code for both Prolia® and XGEVA® is J0897

Amgen is pleased to announce that the Centers for Medicare and Medicaid Services (CMS) have established a product-specific Healthcare Common Procedures Coding System (HCPCS) J-code, or permanent code, for Prolia® (denosumab) and XGEVA® (denosumab).  Effective for dates of service on or after January 1, 2012, the new J-code for both Prolia® and XGEVA® is J0897

The new J-code, J0897 for Prolia® and for XGEVA®, should be used instead of the current miscellaneous J-code (J3590) as well as the current C-code (C9272) when processing claims forms with dates of service on or after January 1, 2012.

The new J0897 code is included in the 2012 version of coding manuals that providers rely on for coding information. We encourage that this new code be implemented within the first 90 days of the calendar year, to allow for a smooth transition in processing physician claims.